Nanalysis Scientific Corp based in the Canadian city of Calgary announced in a press release that it has entered into a letter of intent to acquire QUAD Systems AG. QUAD Systems was established in Dietlikon in the canton of Zurich in 2020. It specializes in Nuclear Magnetic Resonance (NMR), an analysis method used in many industries including pharma.
Nanalysis Scientific also operates in the field of NMR. The company develops and manufactures portable NMR spectrometers and analyzers for laboratory and industrial markets. With this acquisition, Nanalysis Scientific intends to strengthen its position on the NMR market and drive forward innovation. The Canadian company highlights the “world class team” assembled by the founder of QUAD Systems, Klemens Kessler. Based in the Greater Zurich Area, QUAD Systems already holds some key patents.
The planned acquisition builds on an existing strategic partnership between the two companies. A team at Nanalysis Scientific have been working with QUAD Systems AG for over a year in a collaborative agreement for new developments.
As part of the agreement, Nanalysis has provided QUAD Systems with a loan of 1 million francs, which is convertible into shares in the capital of QUAD Systems. Until 1 July 2023, Nanalysis has an option to acquire 100 percent of the issued and outstanding shares of QUAD Systems at a pre-set valuation formula in a combination of cash and Nanalysis shares.
Where life science meets innovation
Do you want to be close to major players, innovative start-ups and leading research institutes in the life sciences space? The Greater Zurich Area has evolved into a dynamically expanding life sciences hotspot, thanks to the region’s academic excellence, business-friendly regulations, IP protection, large international talent pool and R&D collaborations between universities and start-ups, as well as large multinational corporations.
It is no coincidence that the Greater Zurich Area is home to so many world-class patents for medical technology as nowhere else in Europe. Technology leaders such as Roche Diagnostics, Zimmer Biomet, Stryker, Hamilton, Sonova, Cardinal Health and DePuy Synthes (Johnson&Johnson) operate headquarters or research and production facilities here. They value the large pool of international specialists, the R&D collaborations with leading universities and start-ups, the protection of intellectual property and the business-friendly environment. Would your medtech company also like to write a success story in Switzerland?